Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
245
-
Total shares
-
4.61M
-
Shares change
-
-127K
-
Total reported value, excl. options
-
$706M
-
Value change
-
-$19.9M
-
Put/Call ratio
-
0
-
Number of buys
-
80
-
Number of sells
-
-107
-
Price
-
$153.14
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2023
246 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2023.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.61M shares
.
Largest 10 shareholders include MORGAN STANLEY (846K shares), WELLS FARGO & COMPANY/MN (446K shares), BANK OF AMERICA CORP /DE/ (358K shares), UBS Group AG (277K shares), Raymond James Financial Services Advisors, Inc. (245K shares), Royal Bank of Canada (227K shares), LPL Financial LLC (197K shares), RAYMOND JAMES & ASSOCIATES (132K shares), Berger Financial Group, Inc (110K shares), and OSAIC HOLDINGS, INC. (98.9K shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.